Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

ELDNELDN
7 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in ELEDON PHARMACEUTICALS INC

BANK OF AMERICA CORP /DE/ holds 883,097 shares of ELDN (ELEDON PHARMACEUTICALS INC), worth $3.5M as of 2026-Q2. The position was increased (+1.6% shares). ELDN represents 0.0% of BANK OF AMERICA CORP /DE/'s portfolio.

Current Value

$3.5M

Current Shares

883,097

Total Value Change

+$3.1M

Total Shares Change

+787,955

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
883,097
+1.6%
$3.5M0.0%$3.94
27
2026-Q1
Increased
869,544
+1346.9%
$2.7M0.0%$2.50
42
2025-Q4
Increased
60,098
+32.9%
$90,7480.0%$1.51
19
2025-Q3
Increased
45,229
+78.3%
$117,1440.0%$2.54
23
2025-Q2
Increased
25,367
+261.8%
$68,7450.0%$2.69
23
2025-Q1
Decreased
7,012
-92.6%
$23,7710.0%$3.35
0
2024-Q4
New
95,142
-
$391,9850.0%$4.14
36

Other major holders of ELDN: BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used